CORVERT

This brand name is authorized in Austria, Canada, Finland, Netherlands, United States

Active ingredients

The drug CORVERT contains one active pharmaceutical ingredient (API):

1 Ibutilide
UNII 9L5X4M5L6I - IBUTILIDE FUMARATE

Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).

Read about Ibutilide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01BD05 Ibutilide C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02242470
Country: FI Lรครคkealan turvallisuus- ja kehittรคmiskeskus Identifier(s): 448944
Country: NL Z-Index G-Standaard Identifier(s): 14143585
Country: NL Z-Index G-Standaard, PRK Identifier(s): 101834
Country: US FDA, National Drug Code Identifier(s): 0009-3794

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.